Subdividing ART patients and analyzing the medical burden by modeling of CD4 cell count

Li Min1,2, Wang Qunwei1

  • 1College of Economics and Management, Nanjing University of Aeronautics and Astronautics, Nanjing, Jiangsu, China.

Insights

This study used CD4 cell counts to classify patients on antiretroviral therapy (ART) for HIV/AIDS. Subdividing patients based on immune response and adherence helps reduce the medical burden associated with lifelong ART.

Area of Science:

  • Immunology
  • Public Health
  • Data Science

Background:

  • Antiretroviral therapy (ART) is crucial for managing human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS).
  • Lifelong ART imposes a significant medical burden on patients.
  • Subdividing patients could optimize treatment and reduce healthcare costs.

Purpose of the Study:

  • To classify human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) patients undergoing antiretroviral therapy (ART).
  • To model CD4 cell count to stratify patients based on immune recovery and treatment adherence.
  • To analyze and identify strategies for reducing the medical burden associated with ART.

Main Methods:

  • Utilized a recency-frequency (RF) model to preserve data of non-churn ART patients from August 2009 to December 2020.
  • Applied common factor analysis (CFA) to baseline, mean, and last CD4 cell counts to identify critical variables.
  • Employed k-means modeling to subdivide ART patients into distinct groups based on CD4 cell count dynamics.

Main Results:

  • Successfully preserved data for 12,106 non-churn ART patients.
  • Classified patients into 15 distinct types based on compliance and immune reconstitution (CD4 cell count).
  • Identified that poor compliance and immune reconstitution significantly increase patient visits and examination fees, contributing to a higher medical burden.

Conclusions:

  • CD4 cell count is a key indicator for assessing immune recovery post-ART and a critical variable for patient stratification.
  • Patient adherence and immune reconstitution are primary determinants of medical burden in ART management.
  • Stratification based on CD4 cell count and adherence can inform targeted interventions to reduce the economic and healthcare impact of lifelong ART.
Abstract

Related Concept Videos